• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

CMXHF:US

63.2000 USD 1.4000 2.17%

As of 20:10:00 ET on 04/14/2014.

Snapshot for CSL Ltd (CMXHF)

Open: 63.2000 Day's Range: 63.2000 - 63.2000 Volume: 191
Previous Close: 64.6000 52wk Range: 54.8000 - 66.0000 1-Yr Rtn: -

Stock Chart for CMXHF

No chart data available.
  • CMXHF:US 63.2000
  • 1D
  • 1M
  • 1Y
64.6000
Interactive CMXHF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CMXHF

Current P/E Ratio (ttm) -
Estimated P/E(06/2014) 22.7175
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (06/2014) 2.7820
Est. PEG Ratio 1.8058
Market Cap (M USD) 30,378.54
Shares Outstanding (M) 480.67
30 Day Average Volume 249
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 1.67%
Cash Dividend (AUD) 0.5888
Dividend Ex-Date 03/05/2014
5 Year Dividend Growth 22.91%
Next Earnings Announcement 08/14/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CMXHF

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CMXHF

CSL Limited develops, manufactures and markets human pharmaceutical and diagnostic products derived from human plasma. The Company's products include pediatric and adult vaccines, infection and pain medicine, skin disorder remedies, antivenoms, anticoagulants and immunoglobulins.

John ShineChairmanPaul PerreaultCEO/Managing Director
Gordon NaylorChief Financial OfficerGregory Boss "Greg"Exec VP:Legal/Gen Cnsl
More Company Profile & Key Executives for CMXHF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil